BamSEC and AlphaSense Join Forces
Learn More

Travere Therapeutics Inc.

NASDAQ: TVTX    
Share price (1/7/25): $19.08    
Market cap (1/7/25): $1.489 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment of Bylaws of Travere Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Travere Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Retrophin, Inc
12/34/56
EX-3.1
from 8-K 14 pages Amended and Restated Bylaws of Travere Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 15 pages Amended and Restated Bylaws of Retrophin, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Retrophin, Inc. [Remainder of Page Intentionally Left Blank]
12/34/56
EX-3.1
from 8-K 1 page Amendment to Amended and Restated Bylaws of Retrophin, Inc
12/34/56
EX-3.1
from 8-K 14 pages Amended and Restated Bylaws of Retrophin, Inc
12/34/56
EX-3.1
from 8-K 4 pages Certificate of Ownership and Merger Merging Retrophin, Inc. With and Into Desert Gateway, Inc. Pursuant to Section 253 of the General Corporation Law of the State of Delaware
12/34/56
EX-3
from 10-12G/A 21 pages Meetings of Stockholders
12/34/56
EX-3
from 10-12G/A 4 pages Certificate of Incorporation of Desert Gateway, Inc a Delaware Corporation
12/34/56
EX-3
from 10-12G/A 21 pages Meetings of Stockholders
12/34/56
EX-3
from 10-12G/A 4 pages Certificate of Incorporation of Desert Gateway, Inc a Delaware Corporation
12/34/56
EX-3
from 10-12G 21 pages Meetings of Stockholders
12/34/56
EX-3
from 10-12G 4 pages Certificate of Incorporation of Desert Gateway, Inc a Delaware Corporation
12/34/56